Your browser doesn't support javascript.
loading
GLP-1 receptor agonists (GLP-1RAs): cardiovascular actions and therapeutic potential.
Ma, Xiaoxuan; Liu, Zhenghong; Ilyas, Iqra; Little, Peter J; Kamato, Danielle; Sahebka, Amirhossein; Chen, Zhengfang; Luo, Sihui; Zheng, Xueying; Weng, Jianping; Xu, Suowen.
Affiliation
  • Ma X; Institute of Endocrine and Metabolic Diseases, The First Affiliated Hospital USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230001, China.
  • Liu Z; Institute of Endocrine and Metabolic Diseases, The First Affiliated Hospital USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230001, China.
  • Ilyas I; Institute of Endocrine and Metabolic Diseases, The First Affiliated Hospital USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230001, China.
  • Little PJ; Sunshine Coast Health Institute, University of the Sunshine Coast, Birtinya, QLD 4575, Australia.
  • Kamato D; School of Pharmacy, Pharmacy Australia Centre of Excellence, the University of Queensland, Woolloongabba, Queensland 4102, Australia.
  • Sahebka A; School of Pharmacy, Pharmacy Australia Centre of Excellence, the University of Queensland, Woolloongabba, Queensland 4102, Australia.
  • Chen Z; Halal Research Center of IRI, FDA, Tehran, Iran.
  • Luo S; Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad, Iran.
  • Zheng X; Changshu Hospital Affiliated to Soochow University, Changshu No.1 People's Hospital, Changshu 215500, Jiangsu Province, China.
  • Weng J; Institute of Endocrine and Metabolic Diseases, The First Affiliated Hospital USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230001, China.
  • Xu S; Institute of Endocrine and Metabolic Diseases, The First Affiliated Hospital USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230001, China.
Int J Biol Sci ; 17(8): 2050-2068, 2021.
Article in En | MEDLINE | ID: mdl-34131405
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiovascular Diseases / Diabetes Mellitus, Type 2 / Atherosclerosis / Glucagon-Like Peptide-1 Receptor / Hypoglycemic Agents Type of study: Prognostic_studies Limits: Humans Language: En Journal: Int J Biol Sci Journal subject: BIOLOGIA Year: 2021 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiovascular Diseases / Diabetes Mellitus, Type 2 / Atherosclerosis / Glucagon-Like Peptide-1 Receptor / Hypoglycemic Agents Type of study: Prognostic_studies Limits: Humans Language: En Journal: Int J Biol Sci Journal subject: BIOLOGIA Year: 2021 Document type: Article Affiliation country: Country of publication: